A Phase 4 interventional study of Duphastone in Miscarriage Threatening, sponsored by Konya Meram State Hospital. Status unknown. Open to female participants aged 18 Years to 30 Years. Per ClinicalTrials.gov, last updated 2022-09-15.
Sponsored by Konya Meram State Hospital · Phase 4, Interventional, and Treatment
In this study, we aimed to compare the effects of two drugs used for the threated miscarriage on the miscarriage rate.
About 140 pregnant women who applied to our clinic due to the threated miscarriage in the first trimester will be randomly given micronized progesterone to half and dydrogesterone to the other half. After the treatment, the miscarriage rates in the groups will be compared.
320 studies on the registry are indexed under Abortion, Spontaneous; 53 are open to participants now.
This study's planned enrollment of 140 is close to the median of 147 across 174 interventional studies indexed under Abortion, Spontaneous.
Browse Abortion, Spontaneous studies →Konya Meram State Hospital is the lead sponsor of 45 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Micronized progesterone will be given to 70 pregnant women with threated miscarriage.
Drug: Duphastone
Dydrogesterone will be given to 70 pregnant women with threated miscarriage.
Drug: Duphastone
dydrogesterone hormone
Miscarriage rate
Effects of two drugs to be used on live birth rate in pregnant women with threated miscarriage
Time frame: One year
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Konya Meram State Hospital